Established in 1967, the mission of the Crohn’s & Colitis Foundation is to cure Crohn’s disease and ulcerative colitis and to improve the quality of life of children and adults affected by these diseases.
To that end, the foundation is inviting applications for its Senior Research Awards program. Through the program, grants of up to $105,000 a year in direct costs (plus $10,500 in indirect costs) for up to three years will be awarded to senior researchers in support of innovative research in the basic, translational, and clinical biosciences that is likely to increase the understanding of the etiology, pathogenesis, therapy, and prevention of inflammatory bowel disease (IBD).
A focus on human mechanisms in IBD is particularly important for preclinical research. Recipients of the senior research award should generate findings that have an impact on the field of IBD and advance the mission of the foundation, as evaluated by various measures, including follow-on funding from other sources such as the National Institutes of Health (NIH), publications with high impact, and related patents or citations within patents.
To be eligible, applicants must hold an MD, PhD, or equivalent terminal degree and must be employed by an institution (public nonprofit, private nonprofit, or government) engaged in health care and/or health-related research. Eligibility is not restricted by citizenship or geography.
Letters of Intent are due November 5. Upon review, selected applicants will be invited to submit a full proposal by January 28, 2020.
See the Crohn’s & Colitis Foundation website for compete program guidelines and application instructions.